Blood Culture Test Market Size, Share & Forecast to 2030

The Blood Culture Test Market grew from USD 4.49 billion in 2024 to USD 4.78 billion in 2025. It is expected to continue growing at a CAGR of 6.21%, reaching USD 6.44 billion by 2030.

Setting the Stage for Innovation in Blood Culture Testing

Blood culture testing stands at the forefront of infectious disease diagnostics, playing a critical role in the timely identification of bloodstream pathogens and the effective management of sepsis. Rising prevalence of antibiotic-resistant organisms and growing demand for rapid, accurate diagnostic solutions have propelled blood culture analyses from traditional laboratory workflows into advanced, integrated platforms. As healthcare systems globally prioritize patient safety and cost containment, the importance of reliable culture techniques that deliver actionable results cannot be overstated. This executive summary delves into the key drivers, challenges, and opportunities shaping this vital segment.

Our exploration begins by examining the dynamic technological, regulatory, and market forces redefining blood culture testing. We then assess the strategic impact of upcoming United States tariff adjustments, followed by a nuanced segmentation analysis that reveals where high-growth pockets and unmet needs coincide. Regional market nuances provide further clarity on geographic priorities, while company profiling highlights the competitive moves steering innovation and market share. Finally, we present actionable recommendations for industry leaders and outline our rigorous research methodology. Together, these insights offer a cohesive roadmap for stakeholders to navigate a rapidly evolving landscape and capitalize on emerging opportunities.

Rapid Technological Advancements Redefining Diagnostic Landscapes

In recent years, the blood culture testing landscape has undergone transformative shifts driven by breakthroughs in automation, molecular diagnostics, and digital integration. Laboratories are increasingly adopting high-throughput instruments that streamline sample processing and reduce manual intervention, while molecular platforms accelerate pathogen identification down to the species and resistance gene level. Artificial intelligence and data analytics are enhancing interpretation accuracy, enabling predictive insights that guide antimicrobial stewardship initiatives.

Concurrently, the decentralization of healthcare delivery has sparked demand for point-of-care culture techniques capable of delivering rapid results at the patient’s bedside. This shift challenges traditional central lab dominance, prompting vendors to develop compact, user-friendly systems that bridge clinical settings. Regulatory agencies have also evolved their frameworks to accommodate novel testing modalities, balancing patient safety with the need to foster innovation. As a result, partnerships between diagnostic developers, software companies, and healthcare providers are proliferating, setting the stage for a more connected and efficient diagnostic ecosystem.

Anticipating the Consequences of 2025 US Tariff Adjustments on Supply Chains

Looking ahead to 2025, proposed adjustments to United States import tariffs are poised to exert significant influence over the blood culture test supply chain. Increased duties on key raw materials and finished diagnostic instruments risk elevating costs for both reagents and analyzers, potentially compressing laboratory budgets and delaying capital expenditures. Suppliers face the dual challenge of mitigating nominal price hikes and preserving product availability amid shifting trade dynamics.

In response, some manufacturers are exploring near-shoring and regional production hubs to bypass the most onerous duties and secure supply continuity. Others may absorb portions of tariff increases or renegotiate long-term agreements to shield end users from sudden cost escalations. While short-term contract adjustments can offer temporary relief, sustained resilience will depend on supply chain diversification and strategic sourcing partnerships. These measures will ultimately determine how laboratories maintain affordability and reliability in an environment of evolving trade policies and economic uncertainty.

Unveiling Market Dynamics through Detailed Segmentation Analysis

An in-depth view of the market requires a clear understanding of product segmentation, which bifurcates the offering into consumables and instruments. Consumables encompass essential components such as bottles, culture media, and reagent kits, while instruments include analyzers and automation systems designed to optimize workflow and throughput. From an end user perspective, the market spans ambulatory care centers, blood banks, diagnostic laboratories, and hospitals and clinics; independent clinics and physician offices operate within ambulatory settings, whereas diagnostic workflows are further subdivided between hospital-based and independent laboratories, and hospital sites range from secondary to tertiary care facilities.

Technological segmentation reveals a split between conventional culture methods and molecular platforms, with advanced techniques such as next generation sequencing and polymerase chain reaction driving higher precision in pathogen identification. Test type considerations examine the balance between automated systems that enhance efficiency and manual protocols that retain widespread applicability in resource-constrained settings. Application segmentation highlights categories such as bacterial, fungal, and mycobacterial testing, with bacterial assessments diving into gram-negative and gram-positive strains and fungal evaluations covering filamentous fungi and yeast. Sample type differentiation focuses on plasma versus whole blood matrices, while mode of deployment distinguishes central laboratory installations from point-of-care solutions, the latter further defined by bedside and portable formats. Together, these layers of segmentation illuminate the converging demands that shape product development, market positioning, and growth trajectories.

Regional Market Nuances Driving Strategic Priorities Worldwide

Regional insights underscore the nuanced priorities and growth drivers across major global markets. In the Americas, mature healthcare infrastructure, widespread reimbursement frameworks, and established laboratory networks fuel robust demand for both conventional and cutting-edge diagnostic solutions. Laboratories here increasingly prioritize automation and molecular platforms to meet stringent turnaround time targets and antimicrobial stewardship goals.

In Europe, the Middle East, and Africa, regulatory harmonization within the European Union aligns testing standards, yet market maturity varies from advanced Western European nations to rapidly emerging healthcare systems across Eastern Europe, the Middle East, and North Africa. This diversity creates pockets of high growth where improved diagnostic access and funding initiatives converge. Meanwhile, in the Asia-Pacific region, rapid urbanization, rising healthcare spending, and heightened awareness of infectious diseases drive accelerated adoption of advanced blood culture technologies. Local manufacturing partnerships and government-backed healthcare programs further bolster the region’s potential, positioning it as a critical arena for expansion and strategic investment.

Competitive Landscape Shaping Key Players’ Strategic Moves

The competitive landscape in blood culture diagnostics reflects a dynamic interplay of legacy firms and emerging challengers. Leading medical technology corporations leverage deep portfolios that integrate culture systems with complementary diagnostic assays and informatics platforms, emphasizing end-to-end solutions for laboratory efficiency. At the same time, specialized molecular diagnostics companies capitalize on their expertise in sequencing and amplification technologies to deliver rapid pathogen ID and resistance profiling.

Collaborations and strategic acquisitions have become central to growth strategies, enabling companies to expand geographic reach, enhance product breadth, and accelerate innovation cycles. Some players focus on strengthening post-market support, remote service offerings, and digital connectivity to deepen customer loyalty and drive recurring revenue streams. Others invest heavily in research partnerships with academic centers and clinical laboratories to validate novel protocols and extend platform capabilities. As competitive pressures mount, differentiation will hinge on both technological superiority and the ability to deliver seamless, data-driven workflows that align with evolving laboratory and clinical needs.

Strategic Imperatives for Leadership in Blood Culture Diagnostics

Given the evolving market dynamics, industry leaders should pursue a multi-pronged strategy centered on innovation, agility, and collaboration. First, accelerating investments in molecular and digital diagnostic platforms will deliver higher diagnostic yield and more timely results, reinforcing value propositions for laboratory and clinical stakeholders. Second, diversifying supply chains through regional manufacturing hubs and strategic sourcing partnerships will mitigate the impact of trade uncertainties and tariff fluctuations.

Additionally, forging alliances with software providers and healthcare institutions can facilitate seamless data integration, enhance decision support capabilities, and improve patient outcomes. Targeted training programs for laboratory personnel will optimize instrument utilization and reduce operator variability. Finally, establishing flexible pricing and service models can enhance accessibility for smaller laboratories and emerging markets, broadening customer reach and fostering long-term loyalty. By embracing these recommendations, companies can solidify their market positions and drive sustainable growth amidst shifting regulatory, economic, and technological landscapes.

Rigorous Research Framework Underpinning Market Insights

This report is grounded in a robust research framework that combines primary and secondary methodologies to ensure comprehensive, reliable market insights. Primary research involved in-depth interviews with senior executives across diagnostics manufacturers, laboratory directors, and clinical microbiology experts, providing qualitative perspectives on market trends, technology adoption, and strategic priorities. Secondary research encompassed an extensive review of company reports, industry publications, trade data, regulatory filings, and peer-reviewed journals to validate market dynamics and triangulate quantitative data.

Market segmentation logic was developed based on product type, end user, technology, test type, application, sample matrix, and deployment mode, enabling granular analysis of demand drivers and competitive positioning. Data synthesis relied on cross-validation techniques, ensuring consistency between interview findings and published sources. The resulting insights underwent rigorous editorial review and fact-checking procedures to uphold the highest standards of accuracy and objectivity. This methodology provides a transparent foundation for stakeholders to trust and act upon the strategic conclusions presented.

A Cohesive Path Forward in Blood Culture Market Evolution

Blood culture testing remains a pivotal component of modern healthcare, offering critical insights into the diagnosis and management of bloodstream infections. As technological innovation accelerates and healthcare delivery models evolve, stakeholders must navigate complex trade issues, regulatory shifts, and competitive pressures. Detailed segmentation analysis exposes targeted growth pockets, while regional insights highlight distinct market dynamics across the Americas, Europe, Middle East, Africa, and Asia-Pacific.

Competitive intelligence underscores the importance of strategic partnerships, technological differentiation, and service excellence to maintain market leadership. Actionable recommendations guide industry leaders toward investments in molecular platforms, supply chain diversification, and data integration initiatives. Ultimately, the ability to translate data into impactful decisions will determine success in a landscape characterized by rapid change and high stakes. This executive summary illuminates the path forward, equipping decision-makers with the insights needed to drive innovation, optimize operations, and deliver superior patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

Product
- Consumables
  - Bottles
  - Culture Media
  - Reagent Kits
- Instruments
  - Analyzers
  - Automation Systems
End User
- Ambulatory Care Centers
  - Independent Clinics
  - Physician Offices
- Blood Banks
- Diagnostic Laboratories
  - Hospital Based Labs
  - Independent Labs
- Hospitals & Clinics
  - Secondary Hospitals
  - Tertiary Hospitals
Technology
- Conventional
- Molecular
  - Next Generation Sequencing
  - Polymerase Chain Reaction
Test Type
- Automated
- Manual
Application
- Bacterial
  - Gram Negative
  - Gram Positive
- Fungal
  - Filamentous Fungi
  - Yeast
- Mycobacterial
Sample Type
- Plasma
- Whole Blood
Mode
- Central Lab
- Point Of Care
  - Bedside
  - Portable

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

Americas
- United States
  - California
  - Texas
  - New York
  - Florida
  - Illinois
  - Pennsylvania
  - Ohio
- Canada
- Mexico
- Brazil
- Argentina
Europe, Middle East & Africa
- United Kingdom
- Germany
- France
- Russia
- Italy
- Spain
- United Arab Emirates
- Saudi Arabia
- South Africa
- Denmark
- Netherlands
- Qatar
- Finland
- Sweden
- Nigeria
- Egypt
- Turkey
- Israel
- Norway
- Poland
- Switzerland
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Malaysia
- Singapore
- Vietnam
- Taiwan

This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:

Becton Dickinson and Company
bioMérieux SA
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Sysmex Corporation
Accelerate Diagnostics, Inc.
bio-Rad Laboratories, Inc.
Luminex Corporation

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Blood Culture Test Market, by Product

8.1. Introduction
8.2. Consumables
8.2.1. Bottles
8.2.2. Culture Media
8.2.3. Reagent Kits
8.3. Instruments
8.3.1. Analyzers
8.3.2. Automation Systems

9. Blood Culture Test Market, by End User

9.1. Introduction
9.2. Ambulatory Care Centers
9.2.1. Independent Clinics
9.2.2. Physician Offices
9.3. Blood Banks
9.4. Diagnostic Laboratories
9.4.1. Hospital Based Labs
9.4.2. Independent Labs
9.5. Hospitals & Clinics
9.5.1. Secondary Hospitals
9.5.2. Tertiary Hospitals

10. Blood Culture Test Market, by Technology

10.1. Introduction
10.2. Conventional
10.3. Molecular
10.3.1. Next Generation Sequencing
10.3.2. Polymerase Chain Reaction

11. Blood Culture Test Market, by Test Type

11.1. Introduction
11.2. Automated
11.3. Manual

12. Blood Culture Test Market, by Application

12.1. Introduction
12.2. Bacterial
12.2.1. Gram Negative
12.2.2. Gram Positive
12.3. Fungal
12.3.1. Filamentous Fungi
12.3.2. Yeast
12.4. Mycobacterial

13. Blood Culture Test Market, by Sample Type

13.1. Introduction
13.2. Plasma
13.3. Whole Blood

14. Blood Culture Test Market, by Mode

14.1. Introduction
14.2. Central Lab
14.3. Point Of Care
14.3.1. Bedside
14.3.2. Portable

15. Americas Blood Culture Test Market

15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina

16. Europe, Middle East & Africa Blood Culture Test Market

16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland

17. Asia-Pacific Blood Culture Test Market

17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan

18. Competitive Landscape

18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Becton Dickinson and Company
18.3.2. bioMérieux SA
18.3.3. Thermo Fisher Scientific Inc.
18.3.4. Siemens Healthineers AG
18.3.5. Sysmex Corporation
18.3.6. Accelerate Diagnostics, Inc.
18.3.7. bio-Rad Laboratories, Inc.
18.3.8. Luminex Corporation

19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures

FIGURE 1. BLOOD CULTURE TEST MARKET MULTI-CURRENCY
FIGURE 2. BLOOD CULTURE TEST MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables

TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FILAMENTOUS FUNGI, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CENTRAL LAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BEDSIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. CANADA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 94. CANADA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 98. CANADA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 99. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 101. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. CANADA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 104. CANADA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 105. CANADA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 107. CANADA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 198. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 201. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 202. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 214. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 217. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 218. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 220. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 237. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. ITALY BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 239. ITALY BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ITALY BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 242. ITALY BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 243. ITALY BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 244. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. ITALY BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 246. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 247. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. ITALY BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 249. ITALY BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 250. ITALY BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 252. ITALY BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 258. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 259. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 260. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 262. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 263. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 265. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 266. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 267. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 268. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 317. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 318. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 319. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 320. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 322. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 323. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 324. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 326. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 327. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 329. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 330. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 331. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 332. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABL

Companies Mentioned

The companies profiled in this Blood Culture Test market report include:

Becton Dickinson and Company
bioMérieux SA
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Sysmex Corporation
Accelerate Diagnostics, Inc.
bio-Rad Laboratories, Inc.
Luminex Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	May 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 4.78 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.44 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	Global
No. of Companies Mentioned	9

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3245EUR$3,545USD£2,721GBP €3606EUR$3,939USD£3,024GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3501EUR$3,824USD£2,935GBP €3890EUR$4,249USD£3,262GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4745EUR$5,183USD£3,979GBP €5272EUR$5,759USD£4,421GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5742EUR$6,272USD£4,815GBP €6379EUR$6,969USD£5,349GBP

Blood Culture Test Market by Product, End User, Technology, Test Type, Application, Sample Type, Mode - Global Forecast to 2030

Setting the Stage for Innovation in Blood Culture Testing

Rapid Technological Advancements Redefining Diagnostic Landscapes

Anticipating the Consequences of 2025 US Tariff Adjustments on Supply Chains

Unveiling Market Dynamics through Detailed Segmentation Analysis

Regional Market Nuances Driving Strategic Priorities Worldwide

Competitive Landscape Shaping Key Players’ Strategic Moves

Strategic Imperatives for Leadership in Blood Culture Diagnostics

Rigorous Research Framework Underpinning Market Insights

A Cohesive Path Forward in Blood Culture Market Evolution

Market Segmentation & Coverage

Table of Contents

Companies Mentioned

Methodology

Table Information

Setting the Stage for Innovation in Blood Culture Testing

Rapid Technological Advancements Redefining Diagnostic Landscapes

Anticipating the Consequences of 2025 US Tariff Adjustments on Supply Chains

Unveiling Market Dynamics through Detailed Segmentation Analysis

Regional Market Nuances Driving Strategic Priorities Worldwide

Competitive Landscape Shaping Key Players’ Strategic Moves

Strategic Imperatives for Leadership in Blood Culture Diagnostics

Rigorous Research Framework Underpinning Market Insights

A Cohesive Path Forward in Blood Culture Market Evolution

Market Segmentation & Coverage

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Blood Culture Test Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

Automatic Blood Culture Analysis System Market by Product Type, Technology, End User, Application, Sample Type, Distribution Channel - Global Forecast to 2030

Blood Culture Tests - Global Strategic Business Report

Blood Culture Test Market Report by Testing Method, Product, Technology, Application, End User, and Region 2024-2032

Blood Culture Tests Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

About the Blood Culture Test Market